HRP20060009A2 - N-[3-(3-SUBSTITUTED-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL)PHENYL]-SULFONAMIDES, AND METHODS RELATED THERETO - Google Patents

N-[3-(3-SUBSTITUTED-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL)PHENYL]-SULFONAMIDES, AND METHODS RELATED THERETO

Info

Publication number
HRP20060009A2
HRP20060009A2 HR20060009A HRP20060009A HRP20060009A2 HR P20060009 A2 HRP20060009 A2 HR P20060009A2 HR 20060009 A HR20060009 A HR 20060009A HR P20060009 A HRP20060009 A HR P20060009A HR P20060009 A2 HRP20060009 A2 HR P20060009A2
Authority
HR
Croatia
Prior art keywords
pyrazolo
sulfonamides
pyrimidin
phenyl
substituted
Prior art date
Application number
HR20060009A
Other languages
English (en)
Croatian (hr)
Inventor
Anglada Luis
Palomer Albert
Princep Marta
Guglietta Antonio
Original Assignee
Ferrer Internacional
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Internacional filed Critical Ferrer Internacional
Publication of HRP20060009A2 publication Critical patent/HRP20060009A2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
HR20060009A 2003-07-24 2006-01-09 N-[3-(3-SUBSTITUTED-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL)PHENYL]-SULFONAMIDES, AND METHODS RELATED THERETO HRP20060009A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200301746A ES2222813B1 (es) 2003-07-24 2003-07-24 N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados.
ES200401697A ES2245894B1 (es) 2003-07-24 2004-07-12 Mejoras en el objeto de la patente de invencion n.p200301746 que se refiere a "n-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados".
PCT/EP2004/008208 WO2005014597A1 (en) 2003-07-24 2004-07-22 N-[3-(3-SUBSTITUTED-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL)PHENYL]-SULFONAMIDES, AND COMPOSITIONS, AND METHODS RELATED THERETO

Publications (1)

Publication Number Publication Date
HRP20060009A2 true HRP20060009A2 (en) 2006-08-31

Family

ID=34137682

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20060009A HRP20060009A2 (en) 2003-07-24 2006-01-09 N-[3-(3-SUBSTITUTED-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL)PHENYL]-SULFONAMIDES, AND METHODS RELATED THERETO

Country Status (30)

Country Link
US (1) US7947688B2 (es)
EP (1) EP1648897B1 (es)
JP (1) JP2006528608A (es)
KR (1) KR100840450B1 (es)
CN (1) CN100393721C (es)
AR (1) AR047017A1 (es)
AT (1) ATE417048T1 (es)
AU (1) AU2004263278B2 (es)
BR (1) BRPI0412826A (es)
CA (1) CA2532437C (es)
CL (1) CL2004001814A1 (es)
DE (1) DE602004018320D1 (es)
DK (1) DK1648897T3 (es)
EA (1) EA009519B1 (es)
ES (2) ES2222813B1 (es)
HK (1) HK1083844A1 (es)
HR (1) HRP20060009A2 (es)
IL (1) IL173252A0 (es)
MA (1) MA27944A1 (es)
MX (1) MXPA06000754A (es)
NO (1) NO20060580L (es)
NZ (1) NZ544349A (es)
PA (1) PA8607501A1 (es)
PE (1) PE20050254A1 (es)
PL (1) PL1648897T3 (es)
PT (1) PT1648897E (es)
TW (1) TWI340140B (es)
UA (1) UA81959C2 (es)
UY (1) UY28440A1 (es)
WO (1) WO2005014597A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006084835A1 (en) * 2005-02-10 2006-08-17 Ferrer Internacional, S. A. N-(3-(imidazo [1,5-a]pyrimidin-4-yl)phenyl]-sulfonamides and n-[3-(imidazo[1,5-a]pyrimidin-4-yl)-phenyl]-carboxamides and their use as gabaa receptor modulators
EP1736475A1 (en) * 2005-06-21 2006-12-27 Ferrer Internacional, S.A. Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates
JP2009530296A (ja) * 2006-03-17 2009-08-27 ワイス ピラゾロ［１，５−ａ］ピリミジン誘導体およびその使用方法
EP1845098A1 (en) * 2006-03-29 2007-10-17 Ferrer Internacional, S.A. Imidazo[1,2-b]pyridazines, their processes of preparation and their use as GABA receptor ligands
EP1884516A1 (en) 2006-08-04 2008-02-06 Ferrer Internacional, S.A. Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions
EP1956021A1 (en) 2006-10-11 2008-08-13 Ferrer Internacional, S.A. Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound
EP1921079A1 (en) * 2006-11-08 2008-05-14 Ferrer Internacional, S.A. Amorphous form of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
US8163903B2 (en) * 2009-01-13 2012-04-24 Interquim, S.A. Process for the preparation of N-[5-(3-dimethylamino-acryloyl)-2-fluoro-phenyl]-N-methyl-acetamide
WO2013039985A2 (en) * 2011-09-12 2013-03-21 The Johns Hopkins University Serine protease inhibitors
CN102807569B (zh) * 2012-08-21 2015-02-25 四川大学 一种镇静催眠的化合物及其制备方法和用途
SG11201505493QA (en) * 2013-02-21 2015-08-28 Calitor Sciences Llc Heteroaromatic compounds as pi3 kinase modulators

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792533A (fr) * 1971-12-09 1973-06-08 Int Chem & Nuclear Corp Nouvelles pyrazolo (1,5a) pyrimidines et leur procede de preparation
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
US4654347A (en) * 1983-06-23 1987-03-31 American Cyanamid Company Aryl and heteroaryl[[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]methanones
NZ208554A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions
SG30590G (en) * 1985-05-13 1995-09-18 American Cyanamid Co D7-(3-disubstituted amino) phenylaepyrazolod 1,5-aaepyrimidines
EP0264773A1 (en) * 1986-10-16 1988-04-27 American Cyanamid Company 4,5-dihydro and 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidines
DE4333705C2 (de) * 1993-10-02 2003-10-30 Guenter Ege Arylmethylsubstituierte Pyrazolo-azine, insbesondere 3-Arylmethylpyrazolo[1,5-a]pyrimidine und Verfahren zur Herstellung von 8-Arylmethyl-pyrazolo[5,1-c][1,2,4]triazinen
US5538977A (en) * 1995-03-17 1996-07-23 American Cyanamid Company 3-Substituted-7-[3-(imidazol-1-yl)phenyl]-pyrazolo[1,5-a]pyrimidines
DE60014339T8 (de) * 1999-04-02 2006-04-27 Neurogen Corp., Branford Aryl- und heteroaryl-kondensierte aminoalkyl-imidazol-derivate: selektive modulatoren der gabaa-rezeptoren
US6399621B1 (en) * 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto

Also Published As

Publication number Publication date
EA009519B1 (ru) 2008-02-28
BRPI0412826A (pt) 2006-09-26
NZ544349A (en) 2009-05-31
EA200600316A1 (ru) 2006-06-30
TWI340140B (en) 2011-04-11
TW200510422A (en) 2005-03-16
HK1083844A1 (en) 2006-07-14
US20060270690A1 (en) 2006-11-30
CA2532437A1 (en) 2005-02-17
JP2006528608A (ja) 2006-12-21
PL1648897T3 (pl) 2009-07-31
DK1648897T3 (da) 2009-04-06
UA81959C2 (en) 2008-02-25
WO2005014597A1 (en) 2005-02-17
US7947688B2 (en) 2011-05-24
PA8607501A1 (es) 2005-09-28
KR100840450B1 (ko) 2008-06-20
EP1648897B1 (en) 2008-12-10
CA2532437C (en) 2010-01-26
MXPA06000754A (es) 2006-03-30
KR20060030908A (ko) 2006-04-11
CL2004001814A1 (es) 2005-06-03
DE602004018320D1 (de) 2009-01-22
AR047017A1 (es) 2006-01-04
IL173252A0 (en) 2006-06-11
NO20060580L (no) 2006-02-03
UY28440A1 (es) 2004-11-08
ES2222813A1 (es) 2005-02-01
CN1829719A (zh) 2006-09-06
ES2245894A1 (es) 2006-01-16
MA27944A1 (fr) 2006-06-01
PT1648897E (pt) 2009-03-17
ES2222813B1 (es) 2005-12-16
EP1648897A1 (en) 2006-04-26
AU2004263278A1 (en) 2005-02-17
AU2004263278B2 (en) 2009-03-12
ES2245894B1 (es) 2006-12-01
ATE417048T1 (de) 2008-12-15
PE20050254A1 (es) 2005-04-11
CN100393721C (zh) 2008-06-11

Similar Documents

Publication Publication Date Title
HRP20060009A2 (en) N-[3-(3-SUBSTITUTED-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL)PHENYL]-SULFONAMIDES, AND METHODS RELATED THERETO
TW200624432A (en) Imidazo [1,2-a] pyridine compounds, compositions, uses and methods related thereto
MEP45308A (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
EA200500342A1 (ru) Гетероциклические замещённые пиперазины для лечения шизофрении
ME00004B (me) Derivati pirimidina
EA200700047A1 (ru) Новые алкильные производные в качестве метаботропных рецепторов глутамата
DE602006006850D1 (de) Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate
ES2368594T3 (es) Derivados sustituidos de ciclohexilmetilo.
MA31285B1 (fr) Dihydro et tetrahydro oxazolopyrimidinones substituees, preparation et utilisation de celles-ci
RS51136B (sr) Supstituisani pirolopiridini, kompozicije koje ih sadrže, postupak za njihovo dobijanje i upotreba
RS51137B (sr) Derivat benzimidazola i njegova upotreba kao antagonista receptora aii
EA200400892A1 (ru) Производные никотинамида, полезные в качестве ингибиторов pde4
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
TW200745121A (en) Chemical compound
ATE457988T1 (de) A2a-adenosin-rezeptor-antagonisten
ATE420859T1 (de) Azabicycloä3.1.0ühexylphenylderivate als modulatoren von dopamin-d3-rezeptoren
ME00961B (me) Derivati-7 alkinil-1,8-naftiridoni, njihova priprema i njihova primjena u liječenju
HRP20050158A2 (en) Novel 2-arylthiazole compounds as pparalpha and ppargama agonists
EA200800540A1 (ru) Карбоксамидные производные в качестве антагонистов мускариновых рецепторов
GEP20125637B (en) Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them
MA30703B1 (fr) Dérivés de 5,6-bisaryl-2-pyridine-carboxamide, leur préparation et leur application en thérapeutique comme antagonistes des recepteurs a l'urotensine ii.
MA28286A1 (fr) Dérivés de 1-N-phenyl-amino-1H-imidazole et compositions pharmaceutiques les contenant
SE0300092D0 (sv) Novel compounds
MEP26608A (en) Aminothiazole derivatives and their use as crf receptor ligands
SE0300091D0 (sv) Novel compounds

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AKOB Publication of a request for the grant of a patent not including a substantive examination of a patent application (a consensual patent)
ODRP Renewal fee for the maintenance of a patent

Payment date: 20110714

Year of fee payment: 8

OBST Application withdrawn